The present invention provides a method for producing a compound having an alkylated acidic functional group, the method comprising reacting, in a mixture containing two or more compounds having an acidic functional group as substrates, the compounds with an alkylating agent selected from compounds represented by formula A, formula B, or formula C in the presence of a base to alkylate the acidic functional group.

The present invention provides a method for producing a compound having an alkylated acidic functional group, the method comprising reacting, in a mixture containing two or more compounds having an acidic functional group as substrates, the compounds with an alkylating agent selected from compounds represented by formula A, formula B, or formula C in the presence of a base to alkylate the acidic functional group.

The present disclosure provides, for example, a compound represented by the general formula below or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of the compound or salt: ##STR00001##
wherein X.sub.1, X.sub.2, X.sub.3 and X.sub.4 are each independently CR.sub.2? or N?, R.sub.2 is, for example, a halogen atom, R.sub.1 is, for example, S(?O).sub.2NHR.sub.8, R.sub.8 is, for example, a C.sub.1-6 alkyl group, R.sub.3 is, for example, a hydrogen atom, R.sub.5 is, for example, a halogen atom, R.sub.6 is, for example, a hydrogen atom, and R.sub.4 is, for example, a cyclopropyl group. The compounds, salts or solvates provided by the present disclosure exhibit high RAF/MEK complex-stabilizing activity and can be used for the treatment or prevention of cell proliferative disorders, particularly cancers.

The present disclosure provides, for example, a compound represented by the general formula below or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of the compound or salt: ##STR00001##
wherein X.sub.1, X.sub.2, X.sub.3 and X.sub.4 are each independently CR.sub.2? or N?, R.sub.2 is, for example, a halogen atom, R.sub.1 is, for example, S(?O).sub.2NHR.sub.8, R.sub.8 is, for example, a C.sub.1-6 alkyl group, R.sub.3 is, for example, a hydrogen atom, R.sub.5 is, for example, a halogen atom, R.sub.6 is, for example, a hydrogen atom, and R.sub.4 is, for example, a cyclopropyl group. The compounds, salts or solvates provided by the present disclosure exhibit high RAF/MEK complex-stabilizing activity and can be used for the treatment or prevention of cell proliferative disorders, particularly cancers.

The present disclosure provides borate or aluminate activators comprising cations having linear alkyl groups, catalyst systems comprising, and methods for polymerizing olefins using such activators. Specifically, the present disclosure provides activator compounds represented by Formula: [R.sup.1R.sup.2R.sup.3EH].sub.d.sup.+[M.sup.k+Q.sub.n].sup.d-, wherein: E is nitrogen or phosphorous; d is 1, 2 or 3; k is 1, 2, or 3; n is 1, 2, 3, 4, 5, or 6; nk=d; R.sup.1 is C.sub.1-C.sub.20 linear alkyl group; each of R.sup.2 and R.sup.3 is a C.sub.1-C.sub.40 linear alkyl group, a meta- and/or para-substituted phenyl group, an alkoxy group, a silyl group, a halogen, or a halogen containing group, wherein R.sup.1+R.sup.2+R.sup.315 carbon atoms; M is an element selected from group 13, typically B or Al; and each Q is independently a hydride, bridged or unbridged dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, substituted hydrocarbyl, halocarbyl, substituted halocarbyl, or halosubstituted-hydrocarbyl radical, provided that when Q is a fluorophenyl group, then R.sup.2 is not a C.sub.1-C.sub.40 linear alkyl group.

The present disclosure provides borate activators comprising cations having linear alkyl groups, catalyst systems comprising, and processes for polymerizing olefins using such activators. Specifically, the present disclosure provides polymerization activator compounds which may be prepared in, and which are soluble in aliphatic hydrocarbon and alicyclic hydrocarbon solvents.

The present disclosure provides borate or aluminate activators comprising cations having branched alkyl groups, catalyst systems comprising, and methods for polymerizing olefins using such activators. Specifically, the present disclosure provides activator compounds represented by Formula: [R.sup.1R.sup.2R.sup.3EH].sub.d.sup.+[M.sup.k+Q.sub.n].sup.d, wherein: E is nitrogen or phosphorous; d is 1, 2 or 3; k is 1, 2, or 3; n is 1, 2, 3, 4, 5, or 6; nk=d; each of R.sup.1, R.sup.2, and R.sup.3 is independently C.sub.1-C.sub.40 branched or linear alkyl or C.sub.5-C.sub.50-aryl, wherein each of R.sup.1, R.sup.2, and R.sup.3 is independently unsubstituted or substituted with at least one of halide, C.sub.5-C.sub.50 aryl, C.sub.6-C.sub.35 arylalkyl, C.sub.6-C.sub.35 alkylaryl and, in the case of the C.sub.5-C.sub.50-aryl, C.sub.1-C.sub.50 alkyl; wherein R.sup.1, R.sup.2, and R.sup.3 together comprise 15 or more carbon atoms; M is an element selected from group 13 of the Periodic Table of the Elements; and each Q is independently a hydride, bridged or unbridged dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, substituted hydrocarbyl, halocarbyl, substituted halocarbyl, or halosubstituted-hydrocarbyl radical, provided that at least one of R.sup.1, R.sup.2, and R.sup.3 is a branched alkyl.

An aromatic amine derivative having a specific structure, an organic electroluminescence device, and an electronic equipment are provided. The organic electroluminescence device includes organic thin film layers which include a light emitting layer and are disposed between a cathode and an anode. At least one layer of the organic thin film layers includes the aromatic amine derivative. The organic electroluminescence device can be operated at low driving voltage and has high efficiency. The compound achieves the above organic electroluminescence device.

An aromatic amine derivative having a specific structure, an organic electroluminescence device, and an electronic equipment are provided. The organic electroluminescence device includes organic thin film layers which include a light emitting layer and are disposed between a cathode and an anode. At least one layer of the organic thin film layers includes the aromatic amine derivative. The organic electroluminescence device can be operated at low driving voltage and has high efficiency. The compound achieves the above organic electroluminescence device.

An organic electroluminescence device of an embodiment includes a first electrode, a hole transport region disposed on the first electrode, an emission layer disposed on the hole transport region, an electron transport region disposed on the emission layer, and a second electrode disposed on the electron transport region, wherein the hole transport region includes a diamine compound represented by Formula 1, thereby showing high emission efficiency: ##STR00001##